Nanogen Posts Q4 Revenues in Line with Lowered Expectations, Plans to Launch New Products | GenomeWeb

NEW YORK, Jan 31 – Nanogen said Wednesday its fourth quarter revenues rose to $3.0, compared with $2.0 million in the year ago quarter as revenues from sponsored research programs and corporate alliances increased and the company recognized revenue from the sale of its flagship product, the NanoChip Molecular Biology Workstation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."